February 7, 1977

Nuclear Imaging in Benign Diseases of the Brain

Author Affiliations

From the Nuclear Medicine Section, Department of Radiology, Bowman Gray School of Medicine, Winston-Salem, NC.

JAMA. 1977;237(6):575-578. doi:10.1001/jama.1977.03270330065026

FOR some time now, radionuclide imaging of the brain has been a valuable diagnostic tool in the clinical examination of the patient with suspected benign or malignant diseases of the brain. Because of its simplicity, low morbidity, and accuracy, the study can be used both as a screening procedure and as a means to monitor the course of disease following therapy. The ease with which the procedure can be accomplished allows it to be performed as part of an outpatient workup.

This report will confine itself to the value of the procedure in benign diseases and hopefully will be of assistance to clinicians in their everyday practice. Radionuclide examination is useful in the study of patients with a history of head trauma, cerebrovascular disease, suspected inflammatory processes, or arteriovenous malformations. They may also be helpful in the detection of other nonneoplastic brain disorders.

Brain Imaging Technique  At our institution, all